Iht Wealth Management, LLC Dexcom Inc Transaction History

Iht Wealth Management, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$114.22 - $140.1 $169,274 - $207,628	1,482 New	1,482 $205,000
Q4 2021 Feb 14, 2022	SELL	$129.87 - $162.82 $48,311 - $60,569	-372 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$106.71 - $143.18 $13,658 - $18,327	-128 Reduced 25.6%	372 $203,000
Q2 2021 Aug 16, 2021	BUY	$80.99 - $107.93 $40,495 - $53,965	500 New	500 $214,000
Q1 2021 May 18, 2021	SELL	$84.79 - $104.74 $132,950 - $164,232	-1,568 Closed	0 $0
Q4 2020 Feb 17, 2021	BUY	$78.0 - $104.5 $8,034 - $10,763	103 Added 7.03%	1,568 $580,000
Q3 2020 Nov 19, 2020	BUY	$95.51 - $112.95 $11,079 - $13,102	116 Added 8.6%	1,465 $604,000
Q2 2020 Aug 14, 2020	BUY	$62.68 - $105.34 $84,555 - $142,103	1,349 New	1,349 $547,000
Q2 2018 Aug 13, 2018	SELL	$17.54 - $25.22 $3,508 - $5,044	-200 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$11.12 - $15.38 $266 - $369	-24 Reduced 10.71%	200 $11,000
Q3 2017 Nov 14, 2017	BUY	$11.36 - $18.98 $2,544 - $4,251	224	224 $11,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Iht Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Iht Wealth Management, LLC with notifications on news.